Spero Therapeutics, Inc. (SPRO) › Total AssetsSpero Therapeutics, Inc. (SPRO) — Total AssetsAnnual figures by fiscal year, from SEC filings.2016: $13.77M2017: $93.48M2018: $129.01M2019: $106.10M2020: $153.45M2021: $171.07M2022: $124.80M2023: $182.39M2024: $110.54M2025: $68.92M$68.92M2016Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$68.92M-37.7%2024$110.54M-39.4%2023$182.39M+46.1%2022$124.80M-27.0%2021$171.07M+11.5%2020$153.45M+44.6%2019$106.10M-17.8%2018$129.01M+38.0%2017$93.48M+578.8%2016$13.77M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share